Profile
DHR-PB TMO DHR A IDXX IQV
Company Name Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation Agilent Technologies, Inc. IDEXX Laboratories, Inc. IQVIA Holdings Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $916.76B $227.24B $196.87B $45.20B $44.88B $42.12B
Employees 79.00K 122.00K 61.00K 17.70K 11.00K 87.00K
CEO Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Henrik Ancher-Jensen Mr. Jonathan J. Mazelsky Mr. Ari Bousbib
Ratings
Trading
DHR-PB TMO DHR A IDXX IQV
Last Close $1261.26 $595.3 $265.8 $154.23 $543.45 $231.18
High 52 $1261.26 $599.43 $265.8 $154.31 $576.87 $259.1
Low 52 $1261.26 $431.41 $185.1 $101.17 $391.37 $177.16
Price vs. 52 Week High 0 % -0.69 % 0 % -0.05 % -5.79 % -10.78 %
Price vs. 52 Week Low 0 % 37.99 % 43.6 % 52.45 % 38.86 % 30.49 %
Total Return
DHR-PB TMO DHR A IDXX IQV
1 Month Return 0 % 9.93 % 12.46 % 16.45 % 13.74 % 1.77 %
3 Month Return 0 % 8.66 % 6.32 % 14.38 % -2.18 % -3.11 %
6 Month Return 0 % 27.63 % 27.92 % 36.31 % 17.2 % 12.89 %
9 Month Return 0 % 11.82 % 5.72 % 29.33 % 12.35 % 8.04 %
YTD Return 0 % 12.15 % 14.9 % 10.93 % -2.09 % -0.09 %
1 Year Return 0 % 13.71 % 17.39 % 19.43 % 10.44 % 18.28 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DHR-PB TMO DHR A IDXX IQV
Dividend Yield Percentage (TTM) 0.38 % 0.24 % 0.38 % 0.6 % - -
Dividend Paid and Capex Coverage Ration (TTM) 3.16 % 4.68 % 2.65 % 3.39 % 7.41 % 3.58 %
Dividend Per Share (TTM) 1.02 % 1.44 % 1.02 % 0.92 % - -
Payout Ratio (TTM) 17.87 % 8.97 % 27.74 % 21.6 % - -
Growth
DHR-PB TMO DHR A IDXX IQV
Asset Growth 0.16 % 1.62 % 0.16 % 2.35 % 18.68 % 5.3 %
Gross Profit Growth -25.94 % -21.93 % -25.94 % -6.9 % 9.26 % -17.76 %
Revenue Growth -24.09 % -4.58 % -24.09 % -0.22 % 8.72 % 4.13 %
Revenue 3 Year 2.8 % 36.47 % 2.8 % 34.51 % 38.96 % 37.49 %
Revenue 5 Year 14.24 % 83.24 % 14.24 % 51.82 % 72.97 % 59.72 %
Revenue 10 Year 18.09 % 205.6 % 18.09 % 16.86 % 240.27 % 98.74 %
EBIT Growth -40.12 % -12.81 % -40.12 % -16.56 % 22.07 % 15.73 %
Net Income Growth -33.92 % -13.74 % -33.92 % -1.12 % 24.44 % 24.47 %
Net Income 3 Yeari Growth Per Share 25.29 % -3.52 % 25.29 % 81.26 % 49.23 % 406.6 %
Net Income 5 Yeari Growth Per Share 70.95 % 112.51 % 70.95 % 328.44 % 134.38 % 481.09 %
Net Income 10 Yeari Growth Per Share 67.05 % 339.48 % 67.05 % 98.65 % 475.93 % 304.81 %
Operating Income Growth -40.12 % -12.81 % -40.12 % -16.56 % 22.07 % 15.73 %
Operating Cash Flow Growth (CFG) -15.91 % -8.17 % -15.91 % 35.06 % 66.95 % -4.91 %
Operating 3 Year CFG 10.65 % 4.04 % 10.65 % 102.22 % 43.71 % 14.18 %
Operating 5 Year CFG 69.44 % 92.7 % 69.44 % 77.99 % 136.94 % 89.93 %
Operating 10 Year CFG 88.83 % 290.23 % 88.83 % 78.41 % 371.66 % 265.29 %
EPS Growth -34.29 % -12.41 % -34.29 % 0.72 % 25.25 % 26.98 %
EPS Diluted Growth -33.82 % -12.41 % -33.82 % 0.24 % 25.28 % 27.45 %
Book Value Per Share 5.14 % 7.9 % 5.14 % 12.39 % 145.51 % 8.21 %
Share Holder 3 Year Equity Growth Per Share 28.97 % 38.91 % 28.97 % 26.07 % 141.3 % 6.01 %
Share Holder 5 Year Equity Growth Per Share 80.33 % 76.4 % 80.33 % 39.74 % 16418.79 % 0.89 %
Share Holder 10 Year Equity Growth Per Share 125.79 % 158.74 % 125.79 % 28.25 % 266.68 % 718.56 %
Dividend Per Share Growth 50.21 % 16.73 % 50.21 % 7.8 % - -
Dividend 3 Year Growth Per Share 94.58 % 59.21 % 94.58 % 25.46 % - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share 2163.67 % 125.8 % 2163.67 % 97.03 % - -100 %
Debt Growth -0.72 % 1.24 % -0.72 % -1.23 % -29.7 % 9.38 %
Free Cash Flow Growth -21.53 % 0.23 % -21.53 % 44.37 % 96.09 % -5.42 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023 31 Dec 2023 31 Dec 2023
Profitability
DHR-PB TMO DHR A IDXX IQV
Gross Profit Margin TTM 58.45 % 41.2 % 58.4 % 50.63 % 60.14 % 31.38 %
Return on Assets TTM 5.33 % 6.21 % 5.28 % 11.29 % 25.84 % 5.11 %
Return on Equity TTM 8.42 % 13.31 % 8.34 % 21.15 % 63.66 % 22.61 %
Return on Capital Employed TTM 7.39 % 8.44 % 5.54 % 14.19 % 46.55 % 10.37 %
Net Income Per EBT TTM 83.98 % 92.49 % 97.45 % 92.79 % 79.58 % 94.43 %
EBT Per Ebit TTM 94.74 % 92.99 % 107.86 % 100.6 % 97.61 % 68.82 %
EBIT Per Revenue TTM 21.3 % 16.51 % 18.6 % 19.66 % 29.95 % 13.82 %
Cash Flow To Debt Ratio TTM 36.11 % 25.07 % 36.11 % 75.39 % 86.18 % 16.65 %
Receivables Turnover TTM 7.76 4.54 6.66 5.2 6.44 4.37
Payables Turnover TTM 6.49 9.78 5.58 6.81 12.64 3
Inventory Turnover TTM 4.12 4.87 3.54 3.22 3.8 -
Fixed Asset Turnover TTM 463.28 % 455.73 % 397.72 % 458.48 % 449.53 % 1910.62 %
Asset Turnover TTM 31.45 % 43.76 % 27 % 61.52 % 111.07 % 56.87 %
Operating Cash Flow Per Share TTM 9.27 23.37 9.39 6.69 11.09 12.39
Free Cash Flow Per Share TTM 7.39 19.79 7.5 5.63 9.59 8.93
Cash Per Share TTM 937.04 % 1899.74 % 949.37 % 596.59 % 478.28 % 865.86 %
Operating Cash Flow Sales Ratio TTM 26.52 % 21.01 % 30.89 % 29.12 % 24.73 % 14.91 %
Free Cash Flow Operating Cash Flow Ratio TTM 79.76 % 84.68 % 79.89 % 84.09 % 86.5 % 72.05 %
Cash Flow Coverage Ratios TTM 36.11 % 25.07 % 36.11 % 75.39 % 86.18 % 16.65 %
Price To Free Cash Flows Ratio TTM 35.49 30.06 35.43 27.41 56.33 25.94
Price To Operating Cash Flows Ratio TTM 28.67 25.47 28.3 23.04 49.02 18.66
Price Cash Flow Ratio TTM 28.67 25.47 28.3 23.04 49.02 18.66
Income Statement (TTM)
DHR-PB TMO DHR A IDXX IQV
Revenue $23.89B $42.86B $23.89B $6.83B $3.66B $15.01B
Gross Profit $14.03B $15.22B $14.03B $3.47B $2.19B $4.14B
Gross Profit Ratio 58.74% 35.52% 58.74% 50.71% 59.82% 27.56%
EBITDA $7.76B $10.72B $7.76B $1.71B $1.1B $3.21B
Net Income $4.76B $6B $4.76B $1.24B $0.85B $1.36B
EPS Diluted 6.38 15.45 6.38 4.19 10.06 7.29
Balance Sheet (MRQ)
DHR-PB TMO DHR A IDXX IQV
Long Term Debt $17.66B $31.31B $17.66B $2.74B $0.62B $12.96B
Total Liabilities $31B $51.88B $31B $4.92B $1.78B $20.57B
Total Equity $53.49B $46.84B $53.49B $5.85B $1.48B $6.11B
Total Investments $0.01B $-1.92B $0.01B $0.16B $0.06B $0.36B
Total Debt $19.54B $34.92B $19.54B $2.74B $0.95B $14.23B
Total Assets $84.49B $98.73B $84.49B $10.76B $3.26B $26.68B
Cash Flow Statement (TTM)
DHR-PB TMO DHR A IDXX IQV
Net Income $4.22B $6B $4.22B $1.24B $0.85B $1.36B
Inventory $0.19B $0.6B $0.19B $-0.03B $-0.03B $0B
Dividends Paid $-1.25B $-0.52B $-1.25B $-0.27B $0B $0B
Operating Cash Flow $7.16B $8.41B $7.16B $1.77B $0.91B $2.15B
Capital Expenditure $-1.38B $-1.48B $-1.38B $-0.3B $-0.13B $-0.65B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 154.23
ACRS Aclaris Therapeutics, Inc. 1.19
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 2.51
AWH Aspira Women's Health Inc. 2.66
BDSX Biodesix, Inc. 1.575
BIAF bioAffinity Technologies, Inc. 2.26
BIAFW bioAffinity Technologies, Inc. 0.32
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 1.14
BNR Burning Rock Biotech Limited 8.3
CDNA CareDx, Inc 15.5
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 2.185
CNTG Centogene N.V. 0.37
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 221.61
CSTL Castle Biosciences, Inc. 24.24
DGX Quest Diagnostics Incorporated 144.34
DHR Danaher Corporation 265.8
Unlock